A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

Blood - United States
doi 10.1182/blood-2004-01-0326
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Cytarabine Dose for Acute Myeloid Leukemia

New England Journal of Medicine
Medicine
2011English

Transplantation of Autologous Peripheral Blood Progenitor Cells Procured After High-Dose Cytarabine-Based Consolidation Chemotherapy for Adults With Acute Myelogenous Leukemia in First Remission

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1997English

Post-Remission Therapy of Adult Acute Myeloid Leukemia: High Dose Cytosine-Arabinoside Versus Other Consolidation Regimens

Medicinski Pregled
Medicine
2014English

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia

Haematologica
Hematology
2012English

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients With Relapsed/Refractory Acute Myeloid Leukemia

Advances in Hematology
Hematology
2017English

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Efficacy and Toxicity of Idarubicin Versus High-Dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Patients With Acute Myeloid Leukemia andRASMutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy